Are more courses of immunochemotherapy beneficial for the short‐term outcome of locally advanced esophageal squamous cell carcinoma?

Are more courses of immunochemotherapy beneficial for the short‐term outcome of locally advanced esophageal squamous cell carcinoma?

Abstract Background Immune checkpoint inhibitor (ICI) monotherapy and neoadjuvant immunochemotherapy have shown promising results in esophageal carcinoma. However, it is still unclear whether more courses of immunochemotherapy are therapeutically better. We aimed to investigate the safety and effica...

Full description

Bibliographic Details
Main Authors: Yuanheng Huang, Xiaodong Su, Qiyu Guo, Guangyu Luo, Haoqiang He, Peiqiang Cai, Muyan Cai, Haodong Yue, Zhiqiang Wang, Guozhen Yang, Peng Lin, Xu Zhang
Format: Article
Language:English
Published: Wiley 2023-05-01
Series:Thoracic Cancer
Subjects:
esophageal cancer
immunochemotherapy
treatment courses
Online Access:https://doi.org/10.1111/1759-7714.14843

Internet

https://doi.org/10.1111/1759-7714.14843

Similar Items